4.7 Review

Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization

Krzysztof Bartnik et al.

Summary: This study aimed to determine the inter-reader agreement in categorization of imaging features using the LI-RADS LR-TR algorithm in HCC patients treated with cTACE. The results indicated substantial inter-observer agreement in categorizing tumors as viable, non-viable, and equivocal, with further refinement needed for equivocal lesions.

ABDOMINAL RADIOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma

Yeun-Yoon Kim et al.

Summary: In patients with HCC after LRT, incorporation of ancillary MRI features such as TP hypointensity and HBP hypointensity improves the sensitivity of the LI-RADS treatment response algorithm for viable tumor without lowering specificity.

AMERICAN JOURNAL OF ROENTGENOLOGY (2022)

Article Oncology

LI-RADS Treatment Response Algorithm : Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma

Mishal Mendiratta-Lala et al.

Summary: The accuracy of LI-RADS Treatment Response Algorithm (LR-TRA) in assessing the viability of hepatocellular carcinoma (HCC) treated with stereotactic body radiation therapy (SBRT) was evaluated. The study showed that LR-TRA performs well in predicting complete and incomplete necrosis. Unlike other treatment methods, the presence of arterial phase hyperenhancement (APHE) after SBRT does not always indicate viable tumor, suggesting the need for observation in these patients.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Review Gastroenterology & Hepatology

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Maria Reig et al.

Summary: There have been significant advances in the treatment strategies for hepatocellular carcinoma since the last update in 2018. However, some interventions still lack sufficient data for clinical incorporation, and personalized clinical management requires consideration of multiple parameters.

JOURNAL OF HEPATOLOGY (2022)

Review Environmental Sciences

Radiation-induced Cell Death and Its Mechanisms

Yunfei Jiao et al.

Summary: This review discusses the classification and molecular mechanisms of radiation-induced cell death. Understanding the modes and molecular mechanisms of cell death is crucial for the protection, treatment, and recovery of tumors from radiation injury.

HEALTH PHYSICS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology

Naik Vietti Violi et al.

Summary: This study investigated the diagnostic performance of gadoxetate disodium MRI for predicting complete pathologic necrosis (CPN) in HCC treated with TARE. The results showed that the percentage of tumor necrosis on subtraction and EASL criteria were significant independent predictors of CPN, with image subtraction being considered for assessing HCC response to TARE.

EUROPEAN RADIOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization

William E. L. Ormiston et al.

Summary: The study evaluated the prognostic factors in HCC patients treated with locoregional therapy and found a strong association between LR-TR categories and overall survival.

ABDOMINAL RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation

Katerina Mastrocostas et al.

Summary: The study examined the imaging findings of hepatocellular carcinoma (HCC) patients treated with stereotactic body radiation therapy (SBRT) prior to liver transplantation (LT), and found that radiologic assessment may underestimate the degree of tumor necrosis compared to pathology.

ABDOMINAL RADIOLOGY (2021)

Review Medicine, General & Internal

Interreader Reliability of Liver Imaging Reporting and Data System Treatment Response: A Systematic Review and Meta-Analysis

Dong Wook Kim et al.

Summary: In patients with hepatocellular carcinoma, LR-TR demonstrates high interreader reliability regardless of imaging modality. Study heterogeneity is mainly associated with study design and type of treatment.

DIAGNOSTICS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial

Brian S. Letzen et al.

Summary: The study aimed to evaluate the role of 3D quantitative assessment of intra-procedural Lipiodol deposition in liver tumors on CBCT as a predictive biomarker for the outcome of cTACE. Results showed a high degree of agreement between Lipiodol deposition on CBCT and 24 h post-TACE CT, with an inverse correlation between Lipiodol deposition and median overall survival.

CLINICAL IMAGING (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis

Pankaj Gupta et al.

Summary: The study evaluated the diagnostic accuracy of LI-RADS LR-TR criteria in diagnosing viable tumors after locoregional therapies, finding that it has acceptable performance in this aspect. However, further well-designed prospective studies are needed to evaluate criteria for equivocal lesions and the impact of different locoregional therapies.

EUROPEAN RADIOLOGY (2021)

Article Gastroenterology & Hepatology

Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

Riad Salem et al.

Summary: The LEGACY study evaluated the efficacy of yttrium-90 glass microspheres in treating solitary, unresectable HCC <= 8 cm, showing promising response rates and durable responses in a multicenter setting.

HEPATOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of the LI-RADS treatment response algorithm in hepatocellular carcinoma after trans-arterial chemoembolization

Andrea S. Kierans et al.

Summary: The LI-RADS treatment response algorithm (LR-TRA) and modified RECIST (mRECIST) showed no significant difference in diagnostic performance for detecting viable HCC after TACE on MRI, with LR-TRA demonstrating high specificity and moderate sensitivity for this purpose in a North American cirrhotic cohort.

CLINICAL IMAGING (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data

Tae-Hyung Kim et al.

Summary: The LI-RADS TR algorithm demonstrates moderate sensitivity and high specificity for detecting incomplete necrosis after LRT, with arterial phase hyperenhancement being the dominant criterion. Washout contributes to the results to a meaningful extent, while enhancement similar to pretreatment may have a negligible contribution. The type of LRT may affect the algorithm's performance.

ABDOMINAL RADIOLOGY (2021)

Review Oncology

Per-Feature Accuracy of Liver Imaging Reporting and Data System Locoregional Treatment Response Algorithm: A Systematic Review and Meta-Analysis

Yeon Jong Huh et al.

Summary: Locoregional therapy (LRT) is commonly used for hepatocellular carcinoma (HCC) treatment, and post-treatment imaging assessment is crucial for determining tumor viability. The Liver Imaging Reporting and Data Systems (LI-RADS) treatment response (TR) algorithm was developed to standardize image interpretation. Among the LI-RADS TR viable features, arterial phase hyperenhancement (APHE) showed the highest sensitivity and diagnostic odds ratio for diagnosing viable HCC after LRT.

CANCERS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma

Mohammad Chaudhry et al.

RADIOLOGY (2020)

Review Cell Biology

Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer

Joseph Sia et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy

A. A. K. Abdel Razek et al.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Natural history of hepatocellular carcinoma after stereotactic body radiation therapy

Mishal Mendiratta-Lala et al.

ABDOMINAL RADIOLOGY (2020)

Article Oncology

Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up

Mishal Mendiratta-Lala et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy

Erin L. Shropshire et al.

RADIOLOGY (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review

Nicolas Voizard et al.

INSIGHTS INTO IMAGING (2019)

Article Gastroenterology & Hepatology

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach et al.

HEPATOLOGY (2018)

Article Oncology

Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy

Mishal Mendiratta-Lala et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)

Review Oncology

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies

Stephanie K. Schaub et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

LI-RADS Version 2018 Ancillary Features at MRI

Milena Cerny et al.

RADIOGRAPHICS (2018)

Article Gastroenterology & Hepatology

CT Imaging Findings after Stereotactic Radiotherapy for Liver Tumors

Olga R. Brook et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)

Article Oncology

The convergence of radiation and immunogenic cell death signaling pathways

Encouse B. Golden et al.

FRONTIERS IN ONCOLOGY (2012)

Article Cardiac & Cardiovascular Systems

MDCT Versus MRI Assessment of Tumor Response After Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma

Roman Kloeckner et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Added Value of Diffusion-Weighted Imaging in the MRI Assessment of Perilesional Tumor Recurrence After Chemoembolization of Hepatocellular Carcinomas

Jeong-Sik Yu et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres

Ana L. Keppke et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2007)

Review Gastroenterology & Hepatology

Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up

Yong-Song Guan et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2004)